LataMed AI Evaluates Integration of BNPL Payments via Cashea to Expand Healthcare Access in Latin America

LataMed AI Corp. is assessing the integration of installment-based payments through Cashea to reduce financial barriers for patients accessing private healthcare services in Latin America.

Dallas Metrowire Staff
Healthcare
LataMed AI Evaluates Integration of BNPL Payments via Cashea to Expand Healthcare Access in Latin America

LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced it has initiated an operational, technical, and commercial evaluation to potentially integrate installment-based healthcare payment capabilities through Cashea, a leading buy-now-pay-later fintech platform in Venezuela. The initiative aims to reduce upfront financial barriers for patients seeking private healthcare services, including consultations, diagnostics, wellness programs, and other offerings within the LataMed AI ecosystem.

Management believes that improving payment accessibility could enhance patient engagement, increase healthcare utilization, strengthen platform adoption, and broaden access to private healthcare services. By addressing affordability challenges, the company seeks to solidify its position as a technology-enabled healthcare marketplace serving patients, providers, and partners throughout Latin America. A successful integration with Cashea would support LataMed AI's broader strategy of combining artificial intelligence, telehealth infrastructure, care coordination tools, and digital payment accessibility to create a scalable healthcare marketplace.

Dr. Kevin Rodan Levy, CEO of LataMed AI Corp., stated: "We believe financial accessibility is a critical component of healthcare delivery. Our objective is to evaluate solutions that may help patients obtain timely medical care while simultaneously expanding the reach and utility of our healthcare ecosystem." He added that initiatives like this have the potential to strengthen patient acquisition, improve engagement, and support long-term platform growth.

The company has not entered into a definitive commercial agreement as of the release date. Completion of any integration remains subject to further commercial discussions, technical implementation, regulatory review, and customary business conditions. LataMed AI intends to provide updates as material developments occur.

For more information, visit https://latamed.ai or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.

Blockchain Registration

QR Code for Blockchain Registration